# Joseph P. Costantino
**Type:** Researchers
**Canonical URL:** https://scholariq.org/researchers/joseph-p-costantino/
## Facts
| Field | Value |
| --- | --- |
| Citations | 43,254 |
| Field | Breast Cancer Treatment Studies |
| h-index | 81 |
| i10-index | 175 |
| Last Known Institution | United States Air Force Research Laboratory |
| OpenAlex ID | https://openalex.org/A5112208195 |
| Works | 301 |
## Researcher papers
- [Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study](https://scholariq.org/papers/tamoxifen-for-prevention-of-breast-cancer-report-of-the-national-surgical/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer](https://scholariq.org/papers/gene-expression-and-benefit-of-chemotherapy-in-women-with-node-negative-estrogen/)
- [Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial](https://scholariq.org/papers/sentinel-lymph-node-resection-compared-with-conventional-axillary-lymph-node/)
- [Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer](https://scholariq.org/papers/adjuvant-olaparib-for-patients-with-i-brca1-i-or-i-brca2-i-mutated-breast-cancer/)
- [Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial](https://scholariq.org/papers/technical-outcomes-of-sentinel-lymph-node-resection-and-conventional-axillary/)
- [Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial](https://scholariq.org/papers/long-term-primary-results-of-accelerated-partial-breast-irradiation-after-breast/)
- [Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women](https://scholariq.org/papers/projecting-individualized-absolute-invasive-breast-cancer-risk-in-african/)
## Researcher topics
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
## Researcher university
- [United States Air Force Research Laboratory](https://scholariq.org/institutions/united-states-air-force-research-laboratory/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.